ESCAPE Bio is based in South San Francisco, California. It has raised $184M in total funding. Latest round: Series C.
ESCAPE Bio funding overview
ESCAPE Bio is based in South San Francisco, California. ESCAPE Bio has raised $184M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2020. The round record for ESCAPE Bio runs through 2020; nothing later has been disclosed. Investors on record include Wellington Management, Avidity Partners, CAM Capital, New Leaf Ventures, Rock Springs Capital, Surveyor Capital and 8 others. 14 distinct backers are named across the disclosed rounds.
ESCAPE Bio at a glance
Total raised
$184M
Latest round
Series C
Latest round date
September 2020
Headquarters
South San Francisco, California
Notable investors
Wellington Management, Avidity Partners, CAM Capital, New Leaf Ventures, Rock Springs Capital, Surveyor Capital, Sphera Funds Management, OrbiMed
Frequently asked about ESCAPE Bio funding
How much has ESCAPE Bio raised?
ESCAPE Bio has raised $184M in total disclosed funding across the rounds on record.
Who has invested in ESCAPE Bio?
Wellington Management, Avidity Partners, CAM Capital, New Leaf Ventures, Rock Springs Capital, Surveyor Capital are named among the investors backing ESCAPE Bio.
What was the latest ESCAPE Bio funding round?
The most recent disclosed round is a Series C, announced in September 2020.
Where is ESCAPE Bio based?
ESCAPE Bio is based in South San Francisco, California.
When did ESCAPE Bio last raise?
The last disclosed ESCAPE Bio round closed in September 2020 at Series C.
ESCAPE Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in South San Francisco below to benchmark round size and investor mix.
